23-valent Pneumococcal PolysaccharideVaccine

23-valent Pneumococcal PolysaccharideVaccine
Product Description

Covers a wider range of pneumococcal serotypesMore economical for low-and middle-income countries
Patented process
Great immunogenicity and safety
Prefilled Syringe

Chongqing Zhifei Biological Products Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    5000+
Company types
Manufacturer/Innovator

Chongqing Zhifei Biological Products Co., Ltd.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Employees:
    5000+
Company types
Manufacturer/Innovator

More Products from Chongqing Zhifei Biological Products Co., Ltd. (2)

  • Recombinant Mycobacterium Tuberculosis Fusion Protein

    Product Recombinant Mycobacterium Tuberculosis Fusion Protein

    C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening; 
    (2)Non Cross-React with BCG Vaccine; 
    (3)WHO Guideline Recommended;  q...
  • Meningococcal Polysaccharide Vaccine

    Product Meningococcal Polysaccharide Vaccine

    Chongqing zhifei biological products co., ltd offers a wide range of products which includes meningococcal polysaccharide vaccine. Function and use: it can be used to prevent epidemic cerebrospinal meningitis caused by meningococcus group a, c, y, and w135 infection. Contact us for more information.

Chongqing Zhifei Biological Products Co., Ltd. resources (1)